Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents
US8883840B2 · kind B2 · utility
25Cited by
50References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 14, 2012 |
| Grant date | Nov 11, 2014 |
| Priority date | — |
| Expiry date | Sep 14, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/07
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention is directed to the (S)-enantiomer of the compound of formula (I):or a pharmaceutically acceptable solvate or prodrug thereof. This (S)-enantiomer is useful for the treatment of diseases or conditions, such as pain, which are ameliorated or alleviated by the modulation of voltage-gated sodium channels.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.